Andromeda Announces FDA Orphan Drug Designation for DiaPep277 for the …

Andromeda Announces FDA Orphan Drug Designation for DiaPep277 for the …

Filed under: drug treatment news 2012

YAVNE, Israel, May 28, 2012 (GlobeNewswire via COMTEX) — Andromeda Biotech Ltd. today announces that the US Food and Drug Administration (FDA) granted Orphan Drug designation for DiaPep277(R) for the treatment of type 1 diabetes (T1D) patients with …
Read more on MarketWatch (press release)

Fine Treatment Recommends New Safe Thermobalancing Therapy to Replace …

Filed under: drug treatment news 2012

Men with prostate enlargement should consider natural Thermobalancing Therapy as a new effective alternative treatment for prostate enlargement that helps to avoid BPH drugs' side effects and complications from prostate removal procedures, …
Read more on San Francisco Chronicle (press release)

Cipher Pharmaceuticals announces FDA approval of CIP-ISOTRETINOIN

Filed under: drug treatment news 2012

Cipher Pharmaceuticals Inc. (TOR:CA:DND) announced today that the US Food and Drug Administration (FDA) has approved Absorica™, Cipher's novel, patented brand formulation of the acne medication isotretinoin, for the treatment of severe recalcitrant …
Read more on MarketWatch (press release)

More drug treatment news 2012 Resources